Free Trial

SageView Advisory Group LLC Buys 1,243 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background
Remove Ads

SageView Advisory Group LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,487 shares of the healthcare conglomerate's stock after acquiring an additional 1,243 shares during the quarter. SageView Advisory Group LLC's holdings in UnitedHealth Group were worth $5,305,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $28,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter worth $30,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. Finally, Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $32,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on UNH. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Mizuho raised their target price on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Twenty-one research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $632.85.

Remove Ads

Read Our Latest Research Report on UNH

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Down 0.6 %

Shares of NYSE:UNH traded down $3.63 during midday trading on Tuesday, hitting $583.43. 3,865,335 shares of the stock were exchanged, compared to its average volume of 4,340,640. The business's fifty day simple moving average is $514.87 and its two-hundred day simple moving average is $542.12. UnitedHealth Group Incorporated has a 52-week low of $438.50 and a 52-week high of $630.73. The company has a market capitalization of $533.67 billion, a PE ratio of 37.64, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the company posted $5.83 earnings per share. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads